Benzylpenicillin Other names: Penicillin G

Chemical formula: C₁₆H₁₈N₂O₄S  Molecular mass: 334.39 g/mol  PubChem compound: 5904

Therapeutic indications

Benzylpenicillin is indicated for:

Respiratory tract infections

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Respiratory tract infection and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Respiratory tract infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Respiratory tract infection and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial meningitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Bacterial meningitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gas gangrene

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Gas gangrene and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial endocarditis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Bacterial endocarditis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Wound infections, skin and soft tissue infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Local infection of wound
Soft tissue infection
and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Infective otitis media

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Infective otitis media and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteomyelitis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Osteomyelitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tetanus

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Actinomycosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Actinomycotic infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Anthrax

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Anthrax

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leptospirosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rat bite fever

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Rat bite fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Listeriosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Listeriosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lyme disease

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Diphtheria

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Diphtheria caused by Corynebacterium diphtheriae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brain abscess

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Abscess of brain and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pasteurellosis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Pasteurella infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gas gangrene

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Gas gangrene and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial endocarditis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Bacterial endocarditis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Wound infections, skin and soft tissue infections

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

at least one of
Local infection of wound
Soft tissue infection
and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Infective otitis media

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Infective otitis media and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteomyelitis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Osteomyelitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tetanus

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Actinomycosis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Actinomycotic infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Anthrax

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Anthrax

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leptospirosis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rat bite fever

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Rat bite fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Listeriosis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Listeriosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lyme disease

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Diphtheria

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Diphtheria caused by Corynebacterium diphtheriae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pasteurellosis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Pasteurella infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial meningitis

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Bacterial meningitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Brain abscess

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)

Abscess of brain and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Gas gangrene

Population group: only newborns (0 - 40 days old)

Gas gangrene and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Pasteurellosis

Population group: only newborns (0 - 40 days old)

Pasteurella infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Diphtheria

Population group: only newborns (0 - 40 days old)

Diphtheria caused by Corynebacterium diphtheriae

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Lyme disease

Population group: only newborns (0 - 40 days old)

Lyme disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Listeriosis

Population group: only newborns (0 - 40 days old)

Listeriosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Rat bite fever

Population group: only newborns (0 - 40 days old)

Rat bite fever

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Leptospirosis

Population group: only newborns (0 - 40 days old)

Leptospirosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Anthrax

Population group: only newborns (0 - 40 days old)

Anthrax

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Actinomycosis

Population group: only newborns (0 - 40 days old)

Actinomycotic infection

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Tetanus

Population group: only newborns (0 - 40 days old)

Tetanus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteomyelitis

Population group: only newborns (0 - 40 days old)

Osteomyelitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Infective otitis media

Population group: only newborns (0 - 40 days old)

Infective otitis media and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Wound infections, skin and soft tissue infections

Population group: only newborns (0 - 40 days old)

at least one of
Local infection of wound
Soft tissue infection
and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial endocarditis

Population group: only newborns (0 - 40 days old)

Bacterial endocarditis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial meningitis

Population group: only newborns (0 - 40 days old)

Bacterial meningitis and additionally at least one of
Benzylpenicillin susceptible species
Benzylpenicillin susceptible species for which acquired resistance may be a problem

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Benzylpenicillin is contraindicated in the following cases:

Hypersensitivity to penicillins, allergy to other beta-lactams

at least one of
Cephalosporin allergy
Allergy to penicillin
Monobactam allergy
Carbapenem allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2016: BENZYLPENICILLIN SODIUM Powder for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈